Christopher Wilson
I am responsible for commercial development within Personal Care & Consumer Health. I connect industrial challenges with scientific innovation in microbiome science, (digital-) biomarkers and diagnostics to leverage TNO’s expertise and deliver impactful, market-oriented solutions for clients and partners.
At TNO, I focus on translating strategic R&D programs into commercially viable propositions within Personal Care & Consumer Health. My work centres on building and scaling collaborations in microbiome research (skin, oral, vaginal and respiratory), data-driven health, diagnostics and applied life sciences.
I support industrial clients and partners in defining market-driven solutions that align scientific excellence with regulatory, technical and commercial needs. Acting as a bridge between research, engineering, IP strategy and commercial execution, I help move innovation from concept to application.
With over 15 years of senior leadership experience commercialising health-related innovation across start-ups and large enterprises, my expertise lies at the intersection of innovation strategy and implementation, from early validation and proof-of-concept to scale-up, market introduction and post-market regulatory and IP substantiation. This work directly supports TNO’s roadmap in prevention, sustainable healthcare and health technologies with both societal and economic impact.
Contact me for:
- Strategic partnerships in Personal Care & Consumer Health
- Microbiome-based innovation (skin, oral, vaginal, respiratory)
- Point-of-care and in vitro diagnostics
- Healthcare R&D-to-market translation
- Markets served: Aesthetics, Cosmetics, Personal Care, In-Vitro Diagnostics, Medical Devices, Digital Health